YaoGeJuCDE public lists · weekly counts
National Drug-Review Weekly
The available CDE acceptance records list 330 drug applications between 7 October 2022 and 13 October 2022 (data as of 13 November 2026 06:00). Of these, generic applications numbered 74, covering 56 drug names.
2022/10/07 – 2022/10/13
- New acceptances this week
- 330
- Drugs with new generic filings (by drug name, de-duplicated)
- 56
- Accepted this week, now under review
- 0
DefinitionAcceptance numbers accepted this week that still appear on CDE's under-review list at the data cutoff; counted by acceptance date from the daily full pull of that list, independent of snapshot history.
Names with a public page are linked.
New acceptances this week
By application type and drug type
330filings, 74 of them generic
By application type
| Application type | Filings |
|---|---|
| Supplement | 165 |
| Generic | 74 |
| New drug | 62 |
| Import re-registration | 20 |
| Import | 8 |
| Unspecified | 1 |
By drug type
| Drug type | Filings |
|---|---|
| Chemical drug | 252 |
| Therapeutic biologic | 37 |
| TCM | 34 |
| Prophylactic biologic | 7 |
DefinitionAcceptance numbers whose acceptance date falls in this week; application type and drug type are the CDE list's own text, with empty values shown as “Unspecified”.
Most new generic filings, by drug
56 drugs with new generic filings; top 10 listed
| # | Drug | New generic filings | Filing companies | Under review, all years |
|---|---|---|---|---|
| 1 | Diquafosol Sodium Eye Drops | 3 | 2 | 5 |
| 2 | Compound α-Ketoacid Tablets | 2 | 2 | 0 |
| 3 | 丁酸氯维地平注射用乳剂 · No verified English name | 2 | 1 | 0 |
| 4 | Sodium Valproate Concentrated Solution for Injection | 2 | 1 | 0 |
| 5 | 复方醋酸钠林格注射液 · No verified English name | 2 | 1 | 2 |
| 6 | Montelukast Sodium Chewable Tablets | 2 | 1 | 4 |
| 7 | Vonoprazan Fumarate Tablets | 2 | 1 | 60 |
| 8 | Torsemide Injection | 2 | 1 | 1 |
| 9 | Telmisartan Tablets | 2 | 1 | 4 |
| 10 | Piperacillin Sodium And Tazobactam Sodium For Injection | 2 | 1 | 5 |
DefinitionThis week's acceptance numbers with application type “Generic”, grouped by identical drug name; filing companies are de-duplicated by first applicant; under review, all years = acceptance numbers for that name, from any year, still on the CDE under-review list. Top 10 by filings, then companies.
Most new acceptances, by company
210 companies with new acceptances; top 10 listed
| # | Company (first applicant) | Filings | Drugs | Generic |
|---|---|---|---|---|
| 1 | Hainan Pharmaceutical Factory Co., Ltd. Wuhan Branch romanized | 10 | 10 | 0 |
| 2 | Haerbin Jun An Tang Pharmaceuticals Co., Ltd. romanized | 7 | 7 | 0 |
| 3 | AstraZeneca UK Limited | 7 | 1 | 0 |
| 4 | Jiangsu Heng Rui Pharmaceuticals Co., Ltd. romanized | 4 | 2 | 0 |
| 5 | Jiangsu En Hua Pharma Co., Ltd. romanized | 4 | 2 | 0 |
| 6 | Jiangsu Rui Shi Bio Technology Co., Ltd. romanized | 4 | 2 | 4 |
| 7 | Hainan Mei Lan Shi Ke Pharmaceutical Co., Ltd. romanized | 4 | 2 | 0 |
| 8 | Janssen Research & Development， LLC | 4 | 1 | 0 |
| 9 | Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. | 4 | 1 | 0 |
| 10 | Guangxi Ling Yun Xian Pharmaceutical Co., Ltd. romanized | 3 | 3 | 0 |
DefinitionThis week's acceptance numbers grouped by first applicant; drugs are de-duplicated by drug name; “Generic” counts filings with application type “Generic”. Top 10 by filings.
Under-review list changes
Compared across this platform's snapshots of the under-review list
Data collected since 2026/10/22. There is not enough snapshot history for this week yet; counts of filings entering and leaving review start with the next complete week.
DefinitionEntered review = acceptance numbers seen for the first time in this platform's under-review snapshots this week, excluding the baseline records of the first snapshot day (2026/10/22). Left review = acceptance numbers whose last snapshot sighting falls in this week and that this snapshot no longer lists; the outcome follows NMPA's approval-document delivery notices, and numbers without such a record are marked to be checked. Companies are counted by first applicant.
Class 3 and new-drug acceptances
102 this week
| Accepted | Drug | Applicants |
|---|---|---|
| 2022/10/13Import · Class 2.2 | Teclistamab 注射液 · No verified English nameJXSL2200181 | Janssen Research & Development， LLC; Johnson & Johnson (China) Investment Ltd. |
| 2022/10/13Import · Class 2.2 | Teclistamab 注射液 · No verified English nameJXSL2200180 | Janssen Research & Development， LLC; Johnson & Johnson (China) Investment Ltd. |
| 2022/10/13Generic · Class 3 | 醋酸钠林格葡萄糖注射液 · No verified English nameCYHS2201730 | Yang Zi Jiang Pharma Group Shanghai Hai Ni Pharma Co., Ltd. romanized |
| 2022/10/13Generic · Class 3 | 厄贝沙坦氨氯地平片（Ⅲ） · No verified English nameCYHS2201729 | Jiangxi Shimei Pharmaceutical Co., Ltd |
| 2022/10/13Generic · Class 3 | 厄贝沙坦氨氯地平片（Ⅰ） · No verified English nameCYHS2201728 | Jiangxi Shimei Pharmaceutical Co., Ltd |
| 2022/10/13Generic · Class 3 | Compound α-Ketoacid TabletsCYHS2201722 | Beijing Kang Er Fu Pharma Co., Ltd. romanized |
| 2022/10/13Generic · Class 3 | 丁酸氯维地平注射用乳剂 · No verified English nameCYHL2200088 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. |
| 2022/10/13Generic · Class 3 | 丁酸氯维地平注射用乳剂 · No verified English nameCYHL2200087 | CSPC ZHONGNUO PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD. |
| 2022/10/13Generic · Class 3 | ω-3 鱼油中长链脂肪乳/氨基酸（16）/葡萄糖（30%）注射液 · No verified English nameCYHL2200086 | Fujian Sheng Di Pharmaceuticals Co., Ltd. romanized |
| 2022/10/13New drug · Class 2.2 | 注射用维迪西妥单抗 · No verified English nameCXSL2200515 | Rong Chang Biopharmaceutical (Yan Tai) Co., Ltd. romanized |
| 2022/10/13New drug · Class 3.4 | 人纤维蛋白原 · No verified English nameCXSL2200514 | Tong Lu Biopharmaceutical Co., Ltd. romanized |
| 2022/10/13New drug · Class 3.4 | 人纤维蛋白原 · No verified English nameCXSL2200513 | Tong Lu Biopharmaceutical Co., Ltd. romanized |
| 2022/10/13New drug · Class 1 | 自体抗CLL-1嵌合抗原受体T细胞注射液 · No verified English nameCXSL2200512 | Guangzhou Bai Ji Ji Yin Technology Co., Ltd. romanized |
| 2022/10/13New drug · Class 2.2 | 麻腮风联合减毒活疫苗 · No verified English nameCXSL2200511 | Beijing Min Hai Bio Technology Co., Ltd. romanized |
| 2022/10/13New drug · Class 1 | NHL35700片 · No verified English nameCXHL2200793 | Jiangsu En Hua Pharma Co., Ltd. romanized; Shanghai Shu Jing Bio Technology Co., Ltd. romanized |
| 2022/10/13New drug · Class 1 | NHL35700片 · No verified English nameCXHL2200792 | Jiangsu En Hua Pharma Co., Ltd. romanized; Shanghai Shu Jing Bio Technology Co., Ltd. romanized |
| 2022/10/13New drug · Class 1 | NHL35700片 · No verified English nameCXHL2200791 | Jiangsu En Hua Pharma Co., Ltd. romanized; Shanghai Shu Jing Bio Technology Co., Ltd. romanized |
| 2022/10/12Import · Class 1 | CB-5339 胶囊 · No verified English nameJXHL2200299 | Cleave Therapeutics Inc.; CASI Pharmaceuticals (China) Co. Ltd. |
| 2022/10/12Import · Class 1 | CB-5339 胶囊 · No verified English nameJXHL2200298 | Cleave Therapeutics Inc.; CASI Pharmaceuticals (China) Co. Ltd. |
| 2022/10/12Generic · Class 3 | Esomeprazole Magnesium Enteric-Coated CapsulesCYHS2201719 | Zhejiang Er Ying Medicines Co., Ltd. romanized; Zhejiang Jian Feng Pharma Co., Ltd. romanized |
| 2022/10/12Generic · Class 3 | Esomeprazole Magnesium Enteric-Coated CapsulesCYHS2201718 | Zhejiang Er Ying Medicines Co., Ltd. romanized; Zhejiang Jian Feng Pharma Co., Ltd. romanized |
| 2022/10/12Generic · Class 3 | Compound α-Ketoacid TabletsCYHS2201716 | Shanghai Zhi Jian Biopharmaceuticals Technology Co., Ltd. romanized; Shanghai Xin Huang He Pharmaceutical Co., Ltd. romanized |
| 2022/10/12Generic · Class 3 | ω-3鱼油中长链脂肪乳/氨基酸（16）/葡萄糖（16%）注射液 · No verified English nameCYHS2201713 | Sichuan Kelun Pharmaceutical Co., Ltd. |
| 2022/10/12Generic · Class 3 | Calcium Acetate Oral SolutionCYHS2201712 | Shandong Lang Nuo Pharmaceutical Co., Ltd. romanized |
| 2022/10/12Generic · Class 3 | 钠钾镁钙葡萄糖注射液 · No verified English nameCYHS2201707 | Yi Chang Ren Fu Pharma Co., Ltd. romanized; Yi Chang San Xia Pharmaceutical Co., Ltd. romanized |
| 2022/10/12Generic · Class 3 | Betamethasone Sodium Phosphate InjectionCYHS2201703 | Chongqing Huapont Pharmaceutical Co., Ltd. |
| 2022/10/12New drug · Class 1.1 | 小儿二白止痛颗粒 · No verified English nameCXZL2200046 | Ying Ke Rui (Tianjin) Innovation Pharmaceuticals Research Co., Ltd. romanized |
| 2022/10/12New drug · Class 3.3 | 冻干A群C群脑膜炎球菌多糖结合疫苗 · No verified English nameCXSL2200510 | Beijing Ke Xing Zhong Wei Bio Technology Co., Ltd. romanized |
| 2022/10/12New drug · Class 1 | C66胶囊 · No verified English nameCXHL2200790 | Wen Zhou Yi Ke University romanized |
| 2022/10/12New drug · Class 1 | HS-10390片 · No verified English nameCXHL2200789 | Changzhou Heng Bang Pharma Co., Ltd. romanized; Shanghai Han Sen Biopharmaceuticals Technology Co., Ltd. romanized |
72 more not listed (at most 30 rows).
DefinitionThis week's acceptance numbers with application type “New drug”, or registration applications whose class starts with 1, 2 or 3 (supplements and re-registrations excluded); newest first, at most 30 rows.
Subscribe to the weekly
No account needed.
The email carries the same content as this page, in the language you subscribe in: section counts, top-10 lists and definitions, with a link to the full report. Your address is used only to send the report.